WebreSET-O prescription digital therapeutic is a 12-week (84 day) software application intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 … WebPear Therapeutics is not accepting new prescriptions for its products, reSET ®, reSET-O ®, and Somryst ®, nor will refills be dispensed at this time. We will attempt to keep our products available for patients who are already using the products for the duration of the current fill of their prescription, but there can be no assurance that we ...
reSET® & reSET-O® - Pear Therapeutics (US)
WebNov 5, 2024 · Pear's reSET-O for opioid use disorder saves payers $2,150 per patient, real-world claims review finds The study, backed by the digital therapeutics company, … WebreSET-O is a Food and Drug Administration-cleared prescription digital therapeutic (PDT) indicated to improve outpatient-treatment retention of patients with opioid use disorder (OUD). This study examined the cost-effectiveness and budget impact of reSET-O in conjunction with treatment as usual (reSET-O + TAU) relative to TAU. Materials and … reformat graph
「数字疗法第一股」Pear申请破产保护,16个月内市值缩水超百亿 …
WebApr 14, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the business’s stock in a transaction that occurred on Monday, April 10th ... WebOct 16, 2024 · “Pear and Sandoz previously signed a co-promotion agreement and accordingly, Pear has already built a standalone commercial infrastructure capable of supporting reSET, reSET-O and future [prescription digital therapeutics],” Sandoz and Pear wrote in a joint notice yesterday. WebJan 18, 2024 · BOSTON, Jan. 18, 2024, Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital … reformat flash drive puppy linux